These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer. Sun DS; Hu LK; Cai Y; Li XM; Ye L; Hou HY; Wang CH; Jiang YH Asian Pac J Cancer Prev; 2014; 15(3):1233-9. PubMed ID: 24606446 [TBL] [Abstract][Full Text] [Related]
25. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens. Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Takahashi T; Yamanaka T; Seto T; Harada H; Nokihara H; Saka H; Nishio M; Kaneda H; Takayama K; Ishimoto O; Takeda K; Yoshioka H; Tachihara M; Sakai H; Goto K; Yamamoto N Lancet Oncol; 2017 May; 18(5):663-671. PubMed ID: 28343976 [TBL] [Abstract][Full Text] [Related]
28. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. Gondi V; Paulus R; Bruner DW; Meyers CA; Gore EM; Wolfson A; Werner-Wasik M; Sun AY; Choy H; Movsas B Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):656-64. PubMed ID: 23597420 [TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study. Witlox WJA; Ramaekers BLT; Joore MA; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder G; Haitjema T; Ubbels JF; Lagerwaard J; El Sharouni SY; Stigt JA; Smit EF; van Tinteren H; van der Noort V; Groen HJM; De Ruysscher DKM Radiother Oncol; 2020 Mar; 144():65-71. PubMed ID: 31733490 [TBL] [Abstract][Full Text] [Related]
30. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer. Eaton BR; Kim S; Marcus DM; Prabhu R; Chen Z; Ramalingam SS; Curran WJ; Higgins KA Cancer; 2013 Nov; 119(21):3753-60. PubMed ID: 23921891 [TBL] [Abstract][Full Text] [Related]
31. Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study. Chen Y; Wang Y; Ren F; Huang Z; Tan B; Zhao Z; Yu X; Dong P; Yu J; Meng X Respir Res; 2022 Oct; 23(1):274. PubMed ID: 36184624 [TBL] [Abstract][Full Text] [Related]
32. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. Stuschke M; Eberhardt W; Pöttgen C; Stamatis G; Wilke H; Stüben G; Stöblen F; Wilhelm HH; Menker H; Teschler H; Müller RD; Budach V; Seeber S; Sack H J Clin Oncol; 1999 Sep; 17(9):2700-9. PubMed ID: 10561344 [TBL] [Abstract][Full Text] [Related]
34. Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis. Xie SS; Li M; Zhou CC; Song XL; Wang CH PLoS One; 2014; 9(7):e103431. PubMed ID: 25072281 [TBL] [Abstract][Full Text] [Related]
35. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study. Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442 [TBL] [Abstract][Full Text] [Related]
36. Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis. Yin X; Yan D; Qiu M; Huang L; Yan SX BMC Cancer; 2019 Jan; 19(1):95. PubMed ID: 30665432 [TBL] [Abstract][Full Text] [Related]
37. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200 [TBL] [Abstract][Full Text] [Related]
38. Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer. Ding X; Dai H; Hui Z; Ji W; Liang J; Lv J; Zhou Z; Yin W; He J; Wang L Radiat Oncol; 2012 Jul; 7():119. PubMed ID: 22846375 [TBL] [Abstract][Full Text] [Related]
39. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. Robnett TJ; Machtay M; Stevenson JP; Algazy KM; Hahn SM J Clin Oncol; 2001 Mar; 19(5):1344-9. PubMed ID: 11230477 [TBL] [Abstract][Full Text] [Related]
40. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]